Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration

Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration

US Patent 11471412 · Granted Oct 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nanoparticles and nanogel drug compositions for treatment of age-related macular2025
Nanoparticles and nanogel drug compositions for treatment of age-related macular2025
Nanoparticles and nanogel drug compositions for treatment of age-related macular2025
Nanoparticles and nanogel drug compositions for treatment of age-related macular2025
Ophthalmological formulations for the prevention of a coronavirus infection2024
Ophthalmological formulations for the prevention of a coronavirus infection2024
Nanoparticles for treatment of posterior segment ocular diseases and conditions2023
Nanoparticles for treatment of posterior segment ocular diseases and conditions2021
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain 2021
Methods and uses of Nampt activators for treatment of diabetes, cardiovascular d2021
Loteprednol etabonate nanoparticles in thermoreversible gels for enhanced therap2021
Nanoparticles for treatment of posterior segment ocular diseases and conditions2020